Director/PDMR Shareholding

28 Jul 2009 11:10



28 July 2009

GW Pharmaceuticals plc("GW" or "the Company")

SCHEDULE 11 

NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 

The company has today been notified that on 27 July 2009 Dr Geoffrey Guy, a Director of the Company, sold 750,000 ordinary shares of 0.1p to Dr Brian Whittle for consideration of 79 pence per share. Dr Whittle co-founded the Company with Dr Guy and was a Director of the Company until his retirement in 2008. 

In addition, Dr Guy also gifted, for nil consideration, a further 782,111 ordinary shares of 0.1p to Dr Whittle and members of Dr Whittle's family. 

The total transfer of 1,532,111 shares amounts to 1.27% of the issued ordinary share capital.  

Following this notification Dr Guy retains a beneficial interest in 18,323,952 ordinary shares, amounting to 15.17% of the shares in issue.

Enquiries: 

GW Pharmaceuticals plc 01980 557000

Adam George, Company Secretary 

Nominated Adviser 0207 597 5970

Patrick Robb, Investec Bank plc